Mechanistic studies on the drug metabolism and toxicity originating from cytochromes P450

References

• Alves C, Borges R, Da Silva A. 2006. Density functional theory study of metabolic derivatives of the oxidation of paracetamol. Int J Quantum Chem. 106(13):2617–2623.
   Web of Science ®Google Scholar
• Arfeen M, Patel DS, Abbat S, Taxak N, Bharatam PV. 2014. Importance of cytochromes in cyclization reactions: quantum chemical study on a model reaction of proguanil to cycloguanil. J Comput Chem. 35(28):2047–2055.
   PubMed Web of Science ®Google Scholar
• Attia SM. 2010. Deleterious effects of reactive metabolites. Oxid Med Cell Longev. 3(4):238–253.
   PubMed Web of Science ®Google Scholar
• Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer UA. 1989. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Ther. 46(5):521–527.
   PubMed Web of Science ®Google Scholar
• Becke AD. 1993. Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys. 98(7):5648–5652.
   Web of Science ®Google Scholar
• Bharatam PV, Khanna S. 2004. Rapid racemization in thiazolidinediones: a quantum chemical study. J Phys Chem A. 108(17):3784–3788.
   Web of Science ®Google Scholar
• Bharatam PV, Patel DS, Iqbal P. 2005. Pharmacophoric features of biguanide derivatives: an electronic and structural analysis. J Med Chem. 48(24):7615–7622.
   PubMed Web of Science ®Google Scholar
• Blomberg MR, Borowski T, Himo F, Liao R-Z, Siegbahn PE. 2014. Quantum chemical studies of mechanisms for metalloenzymes. Chem Rev. 114(7):3601–3658.
   PubMed Web of Science ®Google Scholar
• Bolton JL, Dunlap T. 2017. Formation and biological targets of quinones: cytotoxic versus cytoprotective effects. Chem Res Toxicol. 30(1):13–37.
   PubMed Web of Science ®Google Scholar
• Boulenc X, Djebli N, Shi J, Perrin L, Brian W, Van Horn R, Hurbin F. 2012. Effects of omeprazole and genetic polymorphism of CYP2C19 on the clopidogrel active metabolite. Drug Metab Dispos. 40(1):187–197.
   PubMed Web of Science ®Google Scholar
• Breck GD, Trager WF. 1971. Oxidative N-dealkylation: a mannich intermediate in the formation of a new metabolite of lidocaine in man. Science. 173(3996):544–546.
   PubMed Web of Science ®Google Scholar
• Caira MR, Ionescu C. 2006. Drug metabolism: current concepts. The Netherlands: Springer Science & Business Media. .
   Google Scholar
• Chen C, Gonzalez FJ, Idle JR. 2007. LC-MS-based metabolomics in drug metabolism. Drug Metab Rev. 39(2–3):581–597.
   PubMed Web of Science ®Google Scholar
• Chen H, Shockcor J, Chen W, Espina R, Gan L-S, Mutlib AE. 2002. Delineating novel metabolic pathways of DPC 963, a non-nucleoside reverse transcriptase inhibitor, in rats. Characterization of glutathione conjugates of postulated oxirene and benzoquinone imine intermediates by LC/MS and LC/NMR. Chem Res Toxicol. 15(3):388–399.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Lamb DC, Kelly SL, Lei L, Guengerich FP. 2010. Cyclization of a cellular dipentaenone by Streptomyces coelicolor cytochrome P450 154A1 without oxidation/reduction. J Am Chem Soc. 132(43):15173–15175.
   PubMed Web of Science ®Google Scholar
• Coen M. 2015. Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity. Drug Metab Rev. 47(1):29–44.
   PubMed Web of Science ®Google Scholar
• Coutts RT, Su P, Baker GB. 1994. Involvement of CYP2D6, CYP3A4, and other cytochrome P-450 isozymes in N-dealkylation reactions. J Pharmacol Toxicol Methods. 31(4):177–186.
   PubMed Web of Science ®Google Scholar
• Cuppoletti A, Dagostin C, Florea C, Galli C, Gentili P, Lanzalunga O, Petride A, Petride H. 1999. The Oxidation of N-benzylaziridine catalyzed by iron porphyrin: radical versus electron transfer mechanism. Chem Eur J. 5(10):2993–2999.
   Web of Science ®Google Scholar
• Dahlin DC, Miwa GT, Lu A, Nelson SD. 1984. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci Usa. 81(5):1327–1331.
   PubMed Web of Science ®Google Scholar
• De Groot MJ. 2006. Designing better drugs: predicting cytochrome P450 metabolism. Drug Discov Today. 11(13–14):601–606.
   PubMed Web of Science ®Google Scholar
• de Montellano P. 2005. Cytochrome P450: structure, mechanism, and biochemistry. New York (US): Springer Science & Business Media.
   Google Scholar
• de Montellano PRO, Nelson SD. 2011. Rearrangement reactions catalyzed by cytochrome P450s. Arch Biochem Biophys. 507(1):95–110.
   PubMed Web of Science ®Google Scholar
• Denisov IG, Makris TM, Sligar SG, Schlichting I. 2005. Structure and chemistry of cytochrome P450. Chem Rev. 105(6):2253–2278.
   PubMed Web of Science ®Google Scholar
• Dinnocenzo J, Karki S, Jones J. 1993. On isotope effects for the cytochrome P-450 oxidation of substituted N, N-dimethylanilines. J Am Chem Soc. 115(16):7111–7116.
   Web of Science ®Google Scholar
• Dixit VA, Bharatam PV. 2011. Toxic metabolite formation from Troglitazone (TGZ): new insights from a DFT study. Chem Res Toxicol. 24(7):1113–1122.
   PubMed Web of Science ®Google Scholar
• Dixit VA, Bharatam PV. 2013. SAR and computer-aided drug design approaches in the discovery of peroxisome proliferator-activated receptorγactivators: a perspective. J Comput Med. 2013:1–38.
   Google Scholar
• Ekins S, Ring BJ, Grace J, McRobie-Belle DJ, Wrighton SA. 2000. Present and future in vitro approaches for drug metabolism. J Pharmacol Toxicol Methods. 44(1):313–324.
   PubMed Web of Science ®Google Scholar
• Frenking G. 2014. Dative Bonds in main-group compounds: a case for more arrows! Angew Chem Int Ed Engl. 53(24):6040–6046.
   PubMed Web of Science ®Google Scholar
• Friesner RA, Guallar V. 2005. Ab initio quantum chemical and mixed quantum mechanics/molecular mechanics (QM/MM) methods for studying enzymatic catalysis. Annu Rev Phys Chem. 56:389–427.
   PubMed Web of Science ®Google Scholar
• Gao J, Truhlar DG. 2002. Quantum mechanical methods for enzyme kinetics. Annu Rev Phys Chem. 53(1):467–505.
   PubMed Web of Science ®Google Scholar
• Garattini S, Marcucci F, Mussini E. 1972. Benzodiazepine metabolism in vitro. Drug Metab Rev. 1(1):291–309.
   Web of Science ®Google Scholar
• Gomes P, Vale N, Moreira R. 2007. Cyclization-activated prodrugs. Molecules. 12(11):2484–2506.
   PubMed Web of Science ®Google Scholar
• Gramec D, Peterlin Mašič L, Sollner Dolenc M. 2014. Bioactivation potential of thiophene-containing drugs. Chem Res Toxicol. 27(8):1344–1358.
   PubMed Web of Science ®Google Scholar
• Grillo MP. 2015. Detecting reactive drug metabolites for reducing the potential for drug toxicity. Expert Opin Drug Metab Toxicol. 11(8):1281–1302.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 2011. Mechanisms of drug toxicity and relevance to pharmaceutical development. Drug Metab Pharmacokinet. 26(1):3–14.
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Yun C-H, Macdonald TL. 1996. Evidence for a 1-electron oxidation mechanism in N-dealkylation of N, N-dialkylanilines by cytochrome p450 2b1 kinetic hydrogen isotope effects, linear free energy relationships, comparisons with horseradish peroxidase, and studies with oxygen surrogates. J Biol Chem. 271(44):27321–27329.
   PubMed Web of Science ®Google Scholar
• Ha-Duong N-T, Dijols S, Macherey A-C, Goldstein JA, Dansette PM, Mansuy D. 2001. Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry. 40(40):12112–12122.
   PubMed Web of Science ®Google Scholar
• Hajovsky H, Hu G, Koen Y, Sarma D, Cui W, Moore DS, Staudinger JL, Hanzlik RP. 2012. Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes. Chem Res Toxicol. 25(9):1955–1963.
   PubMed Web of Science ®Google Scholar
• Hay PJ, Wadt WR. 1985. Ab initio effective core potentials for molecular calculations. Potentials for the transition metal atoms Sc to Hg. J Chem Phys. 82(1):270–283.
   Web of Science ®Google Scholar
• Himmel D, Krossing I, Schnepf A. 2014a. Dative Bonds in main-group compounds: a case for fewer arrows!! Angew Chem Int Ed Engl. 53(2):370–374.
   PubMed Web of Science ®Google Scholar
• Himmel D, Krossing I, Schnepf A. 2014b. Dative or not dative? Angew Chem Int Ed Engl. 53(24):6047–6048.
   PubMed Web of Science ®Google Scholar
• Himo F, Siegbahn PE. 2003. Quantum chemical studies of radical-containing enzymes. Chem Rev. 103(6):2421–2456.
   PubMed Web of Science ®Google Scholar
• Hirao H, Thellamurege N, Chuanprasit P, Xu K. 2013. Importance of H-abstraction in the final step of nitrosoalkane formation in the mechanism-based inactivation of cytochrome P450 by amine-containing drugs. Int J Mol Sci. 14(12):24692–24705.
   PubMed Web of Science ®Google Scholar
• Hirao H, Thellamurege N, Zhang X. 2014. Applications of density functional theory to iron-containing molecules of bioinorganic interest. Front Chem. 2:14
   PubMed Web of Science ®Google Scholar
• Howard-Jones AR, Walsh CT. 2006. Staurosporine and rebeccamycin aglycones are assembled by the oxidative action of StaP, StaC, and RebC on chromopyrrolic acid. J Am Chem Soc. 128(37):12289–12298.
   PubMed Web of Science ®Google Scholar
• Hughes TB, Miller GP, Swamidass SJ. 2015. Modeling epoxidation of drug-like molecules with a deep machine learning network. ACS Cent Sci. 1(4):168–180.
   PubMed Web of Science ®Google Scholar
• Huq F. 2006. Molecular modelling analysis of the metabolism of ibuprofen. J Pharmacol Toxicol. 1(5):456–463.
   Google Scholar
• Im S-C, Waskell LJ,. 2011. The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b5. Arch Biochem Biophys. 507(1):144–153.
   PubMed Web of Science ®Google Scholar
• Iribarne C, Berthou F, Baird S, Dréano Y, Picart D, Bail JP, Beaune P, Ménez JF. 1996. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol. 9(2):365–373.
   PubMed Web of Science ®Google Scholar
• Iribarne C, Picart D, Dréano Y, Bail J-P, Berthou F. 1997. Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes. Life Sci. 60(22):1953–1964.
   PubMed Web of Science ®Google Scholar
• Ismael M, Carpio CAD, Shaikh AR, Tsuboi H, Koyama M, Hatakeyama N, Endou A, Takaba H, Kubo M, Broclawik E, et al. 2007. A DFT study of the heme role in the N-demethylation of theophylline mediated by Compound I of cytochrome P450. Mater Trans. 48(4):730–734.
   Web of Science ®Google Scholar
• Jaladanki CK, Taxak N, Varikoti RA, Bharatam PV. 2015. Toxicity originating from thiophene containing drugs: exploring the mechanism using quantum chemical methods. Chem Res Toxicol. 28(12):2364–2376.
   PubMed Web of Science ®Google Scholar
• Jancova P, Anzenbacher P, Anzenbacherova E. 2010. Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 154(2):103–116.
   PubMed Web of Science ®Google Scholar
• Ji L, Schüürmann G. 2015. Computational biotransformation profile of paracetamol catalyzed by cytochrome P450. Chem Res Toxicol. 28(4):585–596.
   PubMed Web of Science ®Google Scholar
• Jurva U, Bissel P, Isin EM, Igarashi K, Kuttab S, Castagnoli N. 2005. Model electrochemical-mass spectrometric studies of the cytochrome P450-catalyzed oxidations of cyclic tertiary allylamines. J Am Chem Soc. 127(35):12368–12377.
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Didiuk MT. 2009. Structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity? Chem Biodivers. 6(11):2115–2137.
   PubMed Web of Science ®Google Scholar
• Kashiyama E, Yokoi T, Odomi M, Kamataki T. 1999. Stereoselective S-oxidation and reduction of flosequinan in rat. Xenobiotica. 29(8):815–826.
   PubMed Web of Science ®Google Scholar
• Kassahun K, Pearson PG, Tang W, McIntosh I, Leung K, Elmore C, Dean D, Wang R, Doss G, Baillie TA. 2001. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem Res Toxicol. 14(1):62–70.
   PubMed Web of Science ®Google Scholar
• Kathuria D, Arfeen M, Bankar AA, Bharatam PV. 2016. Carbene→ N + coordination bonds in drugs: a quantum chemical study. J Chem Sci. 128(10):1607–1614.
   Web of Science ®Google Scholar
• Kathuria D, Bankar AA, Bharatam PV. 2018. What’s in a structure?” The story of biguanides. J Mol Struct. 1152:61–78.
   Web of Science ®Google Scholar
• Kent UM, Juschyshyn MI, Hollenberg PF. 2001. Mechanism-based inactivators as probes of cytochrome P450 structure and function. Curr Drug Metab. 2(3):215–243.
   PubMed Web of Science ®Google Scholar
• Klopčič I, Dolenc MS. 2019. Chemicals and drugs forming reactive quinone and quinone imine metabolites. Chem Res Toxicol. 32(1):1–34.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Urashima K, Shimada N, Chiba K. 2002. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochem Pharmacol. 63(5):889–896.
   PubMed Web of Science ®Google Scholar
• Koenigs LL, Peter RM, Hunter AP, Haining RL, Rettie AE, Friedberg T, Pritchard MP, Shou M, Rushmore TH, Trager WF. 1999. Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9. Biochemistry. 38(8):2312–2319.
   PubMed Web of Science ®Google Scholar
• Koymans L, Van Lenthe JH, Van de Straat R, Donne-Op den Kelder GM, Vermeulen NP. 1989. A theoretical study on the metabolic activation of paracetamol by cytochrome P-450: indications for a uniform oxidation mechanism. Chem Res Toxicol. 2(1):60–66.
   PubMed Web of Science ®Google Scholar
• Kwiecień RA, Molinié R, Paneth P, Silvestre V, Lebreton J, Robins RJ. 2011. Elucidation of the mechanism of N-demethylation catalyzed by cytochrome P450 monooxygenase is facilitated by exploiting nitrogen-15 heavy isotope effects. Arch Biochem Biophys. 510(1):35–41.
   PubMed Web of Science ®Google Scholar
• Lee C, Yang W, Parr RG. 1988. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev, B Condens Matter. 37(2):785–789.
   PubMed Web of Science ®Google Scholar
• Li C, Wu W, Cho KB, Shaik S. 2009. Oxidation of Tertiary Amines by Cytochrome p450-kinetic isotope effect as a spin-state reactivity probe . Chemistry. 15(34):8492–8503.
   PubMed Web of Science ®Google Scholar
• Li D, Huang X, Lin J, Zhan C-G. 2013. Catalytic mechanism of cytochrome P450 for N-methylhydroxylation of nicotine: reaction pathways and regioselectivity of the enzymatic nicotine oxidation. Dalton Trans. 42(11):3812–3820.
   PubMed Web of Science ®Google Scholar
• Li D, Wang Y, Han K, Zhan C-G. 2010. Fundamental reaction pathways for cytochrome P450-catalyzed 5'-hydroxylation and N-demethylation of nicotine. J Phys Chem B. 114(27):9023–9030.
   PubMed Web of Science ®Google Scholar
• Li D, Wang Y, Yang C, Han K. 2009. Theoretical study of N-dealkylation of N-cyclopropyl-N-methylaniline catalyzed by cytochrome P450: insight into the origin of the regioselectivity. Dalton Trans. (2):291–297.
   PubMed Web of Science ®Google Scholar
• Liu DQ, Arison BH, Stearns RA, Kim D, Vincent SH. 2007. Characterization of two cyclic metabolites of sitagliptin. Drug Metab Dispos. 35(4):521–524.
   PubMed Web of Science ®Google Scholar
• Loew GH, Harris DL. 2000. Role of the heme active site and protein environment in structure, spectra, and function of the cytochrome P450s. Chem Rev. 100(2):407–420.
   PubMed Web of Science ®Google Scholar
• Lonsdale R, Harvey JN, Mulholland AJ. 2012. A practical guide to modelling enzyme-catalysed reactions. Chem Soc Rev. 41(8):3025–3038.
   PubMed Web of Science ®Google Scholar
• Bolton JL. 2014. Quinone methide bioactivation pathway: contribution to toxicity and/or cytoprotection? Curr Org Chem. 18(1):61–69.
   PubMed Web of Science ®Google Scholar
• Manikandan P, Nagini S. 2018. Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets. 19(1):38–54.
   PubMed Web of Science ®Google Scholar
• Masubuchi Y, Horie T. 2007. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs. Crit Rev Toxicol. 37(5):389–412.
   PubMed Web of Science ®Google Scholar
• McMahon RE. 1966. Microsomal dealkylation of drugs: substrate specificity and mechanism. J Pharm Sci. 55(5):457–466.
   Web of Science ®Google Scholar
• Mercer AE, Regan SL, Hirst CM, Graham EE, Antoine DJ, Benson CA, Williams DP, Foster J, Kenna JG, Park BK. 2009. Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene S-oxidation: induction of cell defence, apoptosis and hepatic necrosis. Toxicol Appl Pharmacol. 239(3):297–305.
   PubMed Web of Science ®Google Scholar
• Mesdjian E, Seree E, Charvet B, Mirrione A, Bourgarel-Rey V, Desobry A, Barra Y. 1999. Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies. Life Sci. 64(10):827–835.
   PubMed Web of Science ®Google Scholar
• Meunier B, de Visser SP, Shaik S. 2004. Mechanism of oxidation reactions catalyzed by cytochrome P450 enzymes. Chem Rev. 104(9):3947–3980.
   PubMed Web of Science ®Google Scholar
• Meyer AH, Dybala-Defratyka A, Alaimo PJ, Geronimo I, Sanchez AD, Cramer CJ, Elsner M. 2014. Cytochrome P450-catalyzed dealkylation of atrazine by Rhodococcus sp. strain NI86/21 involves hydrogen atom transfer rather than single electron transfer. Dalton Trans. 43(32):12175–12186.
   PubMed Web of Science ®Google Scholar
• Miller WL, Chung B-C. 2016. The first defect  in electron transfer to mitochondrial p450 enzymes. USA: Oxford University Press.
   Google Scholar
• Moco S, Vervoort J, Moco S, Bino RJ, De Vos RCH, Bino R. 2007. Metabolomics technologies and metabolite identification. Trends Anal Chem. 26(9):855–866.
   Web of Science ®Google Scholar
• Modi AR, Dawson JH. 2015. Oxidizing intermediates in  P450 catalysis: a case for multiple oxidants. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450. Cham: Springer; p. 63–81.
   Google Scholar
• Monks TJ, Jones DC. 2002. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Curr Drug Metab. 3(4):425–438.
   PubMedGoogle Scholar
• Naisbitt DJ, Williams DP, Pirmohamed M, Kitteringham NR, Park BK. 2001. Reactive metabolites and their role in drug reactions. Curr Opin Allergy Clin Immunol. 1(4):317–325.
   PubMed Web of Science ®Google Scholar
• Nelson SD. 1995. Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury. Drug Metab Rev. 27(1-2):147–177.
   PubMed Web of Science ®Google Scholar
• O'Donnell JP, Dalvie DK, Kalgutkar AS, Obach RS. 2003. Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen. Drug Metab Dispos. 31(11):1369–1377.
   PubMed Web of Science ®Google Scholar
• Obach RS, Kalgutkar AS, Ryder TF, Walker GS. 2008. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam. Chem Res Toxicol. 21(9):1890–1899.
   PubMed Web of Science ®Google Scholar
• Okazaki O, Guengerich F. 1993. Evidence for specific base catalysis in N-dealkylation reactions catalyzed by cytochrome P450 and chloroperoxidase. Differences in rates of deprotonation of aminium radicals as an explanation for high kinetic hydrogen isotope effects observed with peroxidases. J Biol Chem. 268(3):1546–1552.
   PubMed Web of Science ®Google Scholar
• Olesen OV, Linnet K. 2000. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine . Br J Clin Pharmacol. 50(6):563–571.
   PubMed Web of Science ®Google Scholar
• Orr ST, Ripp SL, Ballard TE, Henderson JL, Scott DO, Obach RS, Sun H, Kalgutkar AS. 2012. Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks. J Med Chem. 55(11):4896–4933.
   PubMed Web of Science ®Google Scholar
• Paine MJ, Scrutton NS, Munro AW, Gutierrez A, Roberts GC, Wolf CR. 2005. Electron transfer partners of cytochrome P450. In: Cytochrome P450. New York: Springer; p. 115–148.
   Google Scholar
• Park BK, Boobis A, Clarke S, Goldring CEP, Jones D, Kenna JG, Lambert C, Laverty HG, Naisbitt DJ, Nelson S, et al. 2011. Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov. 10(4):292–306.
   PubMed Web of Science ®Google Scholar
• Parker R-E, Isaacs N. 1959. Mechanisms of epoxide reactions. Chem Rev. 59(4):737–799.
   Web of Science ®Google Scholar
• Potter DW, Hinson JA. 1987. Mechanisms of acetaminophen oxidation to N-acetyl-P-benzoquinone imine by horseradish peroxidase and cytochrome P-450. J Biol Chem. 262(3):966–973.
   PubMed Web of Science ®Google Scholar
• Prasad B, Singh S. 2009. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 50(3):475–490.
   PubMed Web of Science ®Google Scholar
• Ramesh M, Bharatam P. 2019. Formation of a toxic quinoneimine metabolite from diclofenac: a quantum chemical study. Drug Metab Lett. 13(1):64–76.
   PubMedGoogle Scholar
• Ramesh M, Bharatam PV. 2014. Importance of hydrophobic parameters in identifying appropriate pose of CYP substrates in cytochromes. Eur J Med Chem. 71:15–23.
   PubMed Web of Science ®Google Scholar
• Reed JR, Backes WL. 2012. Formation of P450 · P450 complexes and their effect on P450 function. Pharmacol Ther. 133(3):299–310.
   PubMed Web of Science ®Google Scholar
• Reilly CA, Ehlhardt WJ, Jackson DA, Kulanthaivel P, Mutlib AE, Espina RJ, Moody DE, Crouch DJ, Yost GS. 2003. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells. Chem Res Toxicol. 16(3):336–349.
   PubMed Web of Science ®Google Scholar
• Remmer H. 1970. The role of the liver in drug metabolism. Am J Med. 49(5):617–629.
   PubMed Web of Science ®Google Scholar
• Roberts KM, Jones JP. 2010. Anilinic N-oxides support cytochrome P450-mediated N-dealkylation through hydrogen-atom transfer. Chemistry. 16(27):8096–8107.
   PubMed Web of Science ®Google Scholar
• RošKar R, LušIn TT, 2012. Analytical methods for quantification of drug metabolites in biological samples. In: Chromatography-the most versatile method of chemical analysis. Rijeka, Croatia: IntechOpen.
   Google Scholar
• Rydberg P, Olsen L, Ryde U. 2012. Quantum-mechanical studies of reactions performed by cytochrome P450 enzymes. CIC. 2(3):292–315.
   Google Scholar
• Salamone S, Colin C, Grillier-Vuissoz I, Kuntz S, Mazerbourg S, Flament S, Martin H, Richert L, Chapleur Y, Boisbrun M. 2012. Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study. Eur J Med Chem. 51:206–215.
   PubMed Web of Science ®Google Scholar
• Sasaki JC, Fellers RS, Colvin ME. 2002. Metabolic oxidation of carcinogenic arylamines by P450 monooxygenases: theoretical support for the one-electron transfer mechanism. Mutat Res. 506–507:79–89.
   PubMed Web of Science ®Google Scholar
• Sato H, Guengerich FP. 2000. Oxidation of 1, 2, 4, 5-tetramethoxybenzene to a cation radical by cytochrome P450. J Am Chem Soc. 122(33):8099–8100.
   Web of Science ®Google Scholar
• Shaffer CL, Harriman S, Koen YM, Hanzlik RP. 2002. Formation of cyclopropanone during cytochrome P450-catalyzed N-dealkylation of a cyclopropylamine. J Am Chem Soc. 124(28):8268–8274.
   PubMed Web of Science ®Google Scholar
• Shaik S, Cohen S, Wang Y, Chen H, Kumar D, Thiel W. 2010. P450 enzymes: their structure, reactivity, and selectivity–modeled by QM/MM calculations. Chem Rev. 110(2):949–1017.
   PubMed Web of Science ®Google Scholar
• Shaik S, Kumar D, de Visser SP, Altun A, Thiel W. 2005. Theoretical perspective on the structure and mechanism of cytochrome P450 enzymes. Chem Rev. 105(6):2279–2328.
   PubMed Web of Science ®Google Scholar
• Shaikh AR, Broclawik E, Tsuboi H, Koyama M, Endou A, Takaba H, Kubo M, Del Carpio CA, Miyamoto A. 2007. Oxidation mechanism in the metabolism of (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]-3-phenylacrylamide on oxyferryl active site in CYP3A4 Cytochrome: DFT modeling. J Mol Model. 13(6–7):851–860.
   PubMed Web of Science ®Google Scholar
• Sharma PK, de Visser SP, Shaik S. 2003. Can a single oxidant with two spin states masquerade as two different oxidants? A study of the sulfoxidation mechanism by cytochrome P450. J Am Chem Soc. 125(29):8698–8699.
   PubMed Web of Science ®Google Scholar
• Sheweita SA. 2000. Drug-metabolizing enzymes: mechanisms and functions. Curr Drug Metab. 1(2):107–132.
   PubMed Web of Science ®Google Scholar
• Siegbahn PE, Blomberg MR. 2010. Quantum chemical studies of proton-coupled electron transfer in metalloenzymes. Chem Rev. 110(12):7040–7061.
   PubMed Web of Science ®Google Scholar
• Silverman RB. 1988. Mechanism-based enzyme inactivation: chemistry and enzymology. Boca Raton: CRC Press.
   Google Scholar
• Sun H, Scott DO. 2011. Metabolism of 4-aminopiperidine drugs by cytochrome P450s: molecular and quantum mechanical insights into drug design. ACS Med Chem Lett. 2(8):638–643.
   PubMed Web of Science ®Google Scholar
• Tao J, Kang Y, Xue Z, Wang Y, Zhang Y, Chen Q, Chen Z, Xue Y. 2015. Theoretical study on the N-demethylation mechanism of theobromine catalyzed by P450 isoenzyme 1A2. J Mol Graph Model. 61:123–132.
   PubMed Web of Science ®Google Scholar
• Taxak N, Bharatam PV. 2010. An insight into the concept and details of mechanism-based inhibition of CYP450. Curr Res Pharm Sci. 11:62–67.
   Google Scholar
• Taxak N, Bharatam PV. 2014. Drug metabolism. Resonance. 19(3):259–282.
   Google Scholar
• Taxak N, Dixit VA, Bharatam PV. 2012. Density functional study on the cytochrome-mediated S-oxidation: identification of crucial reactive intermediate on the metabolic path of thiazolidinediones. J Phys Chem A. 116(42):10441–10450.
   PubMed Web of Science ®Google Scholar
• Taxak N, Kalra S, Bharatam PV. 2013. Mechanism-based inactivation of cytochromes by furan epoxide: unraveling the molecular mechanism. Inorg Chem. 52(23):13496–13508.
   PubMed Web of Science ®Google Scholar
• Taxak N, Parmar V, Patel DS, Kotasthane A, Bharatam PV. 2011. S-oxidation of thiazolidinedione with hydrogen peroxide, peroxynitrous acid, and C4a-hydroperoxyflavin: a theoretical study. J Phys Chem A. 115(5):891–898.
   PubMed Web of Science ®Google Scholar
• Taxak N, Patel B, Bharatam PV. 2013. Carbene generation by cytochromes and electronic structure of heme-iron-porphyrin-carbene complex: a quantum chemical study. Inorg Chem. 52(9):5097–5109.
   PubMed Web of Science ®Google Scholar
• Taxak N, Prasad KC, Bharatam PV. 2013. Mechanistic insights into the bioactivation of phenacetin to reactive metabolites: a DFT study. Comput Theor Chem. 1007:48–56.
   Web of Science ®Google Scholar
• Thompson D, Moldéus P. 1991. Formation and reactivity of a quinone methide in biological systems. In: Biological reactive intermediates IV. Boston, MA: Springer; p. 589–596.
   Google Scholar
• Tomberg A, Pottel J, Liu Z, Labute P, Moitessier N. 2015. Understanding P450-mediated Bio-transformations into Epoxide and Phenolic Metabolites. Angew Chem Int Ed Engl. 54(46):13743–13747.
   PubMed Web of Science ®Google Scholar
• Uchiyama M, Fischer T, Mueller J, Oguchi M, Yamamura N, Koda H, Iwabuchi H, Izumi T. 2010. Identification of novel metabolic pathways of pioglitazone in hepatocytes: N-glucuronidation of thiazolidinedione ring and sequential ring-opening pathway. Drug Metab Dispos. 38(6):946–956.
   PubMed Web of Science ®Google Scholar
• Usia T, Kadota S, Tezuka Y. 2006. Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum. Planta Medica. 72(06):527–532.
   PubMed Web of Science ®Google Scholar
• Veith A, Moorthy B. 2018. Role of cytochrome P450s in the generation and metabolism of reactive oxygen species. Curr Opin Toxicol. 7:44–51.
   PubMedGoogle Scholar
• Vincent SH, Reed JR, Bergman AJ, Elmore CS, Zhu B, Xu S, Ebel D, Larson P, Zeng W, Chen L, et al. 2007. Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C] sitagliptin in humans. Drug Metab Dispos. 35(4):533–538.
   PubMed Web of Science ®Google Scholar
• von Bahr C, Hedlund I, Karlén B, Bäckström D, Grasdalen H. 1977. Evidence for two catalytically different binding sites of liver microsomal cytochrome P-450: importance for species and sex differences in oxidation pattern of lidocaine. Acta Pharmacol Toxicol (Copenh)). 41(1):39–48.
   PubMedGoogle Scholar
• Wallar BJ, Lipscomb JD. 1996. Dioxygen activation by enzymes containing binuclear non-heme iron clusters. Chem Rev. 96(7):2625–2658.
   PubMed Web of Science ®Google Scholar
• Wang Y, Kumar D, Yang C, Han K, Shaik S. 2007. Theoretical study of N-demethylation of substituted N,N-dimethylanilines by cytochrome P450: the mechanistic significance of kinetic isotope effect profiles. J Phys Chem B. 111(26):7700–7710.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li D, Han K, Shaik S. 2010. An acyl group makes a difference in the reactivity patterns of cytochrome P450 catalyzed N-demethylation of substituted N,N-dimethylbenzamides-high spin selective reactions. J Phys Chem B. 114(8):2964–2970.
   PubMed Web of Science ®Google Scholar
• Waskell L, Kim JJP. 2015. Electron transfer partners of Cytochrome P450. In: Cytochrome P450. Switzerland: Springer; p. 33–68.
   Google Scholar
• Watkins W, Sixsmith D, Chulay J. 1984. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. Ann Trop Med Parasitol. 78(3):273–278.
   PubMed Web of Science ®Google Scholar
• Xue Z, Zhang Y, Tao J, Kang Y, Chen Z, Xue Y. 2016. Theoretical elucidation of the metabolic mechanisms of phenothiazine neuroleptic chlorpromazine catalyzed by cytochrome P450 isoenzyme 1A2. Theor Chem Acc. 135(9):218.
   Web of Science ®Google Scholar
• Zhou S, Chan E, Lim LY, Boelsterli UA, Li SC, Wang J, Zhang Q, Huang M, Xu A. 2004. Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4. Curr Drug Metab. 5(5):415–442.
   PubMed Web of Science ®Google Scholar
• Zhou S, Chan SY, Goh BC, Chan E, Duan W, Huang M, McLeod HL. 2005. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet. 44(3):279–304.
   PubMed Web of Science ®Google Scholar